Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2007. Start Trial.
Date Value
October 26, 2026 7.627
October 23, 2026 7.627
October 22, 2026 7.627
October 21, 2026 7.627
October 20, 2026 7.042
October 19, 2026 7.042
October 16, 2026 7.042
October 15, 2026 7.042
October 14, 2026 7.042
October 13, 2026 7.042
October 12, 2026 7.042
October 09, 2026 7.042
October 08, 2026 7.042
October 07, 2026 7.042
October 06, 2026 6.478
October 05, 2026 6.478
October 02, 2026 6.478
October 01, 2026 6.520
September 30, 2026 6.374
September 29, 2026 6.374
September 28, 2026 6.374
September 25, 2026 6.374
September 24, 2026 6.785
September 23, 2026 6.785
September 22, 2026 6.785
Date Value
September 21, 2026 6.785
September 18, 2026 6.785
September 17, 2026 6.785
September 16, 2026 6.785
September 15, 2026 6.785
September 14, 2026 6.785
September 11, 2026 6.785
September 10, 2026 6.785
September 09, 2026 6.785
September 08, 2026 6.785
September 04, 2026 7.923
September 03, 2026 7.923
September 02, 2026 7.923
September 01, 2026 7.923
August 31, 2026 7.923
August 28, 2026 7.923
August 27, 2026 7.923
August 26, 2026 7.923
August 25, 2026 7.923
August 24, 2026 7.923
August 21, 2026 7.923
August 20, 2026 7.923
August 19, 2026 7.923
August 18, 2026 7.923
August 17, 2026 7.923

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Novo Nordisk A/S 5.111
H. Lundbeck A/S 1.654
AstraZeneca PLC 11.27
ANI Pharmaceuticals, Inc. 2.793
Corcept Therapeutics, Inc. 13.32

Price to Book Value Related Metrics